Development and validation of highly predictive anticancer compound screening (HIPACS) systems: impact of tri-dimensional structure and stromal cells on sensitivity of human tumors to drug treatment.

Schrift Standard Fett
Login

Forschungsstelle

INNOSUISSE

Projektnummer

10761.1;5 PFLS-LS

Projekttitel

Development and validation of highly predictive anticancer compound screening (HIPACS) systems: impact of tri-dimensional structure and stromal cells on sensitivity of human tumors to drug treatment.

Projekttitel Englisch

Development and validation of highly predictive anticancer compound screening (HIPACS) systems: impact of tri-dimensional structure and stromal cells on sensitivity of human tumors to drug treatment.

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Kurzbeschreibung	-	-	-
Abstract	-	-	-

Erfasste Texte

Kategorie	Text
Kurzbeschreibung (Englisch)	Development and validation of highly predictive anticancer compound screening (HIPACS) systems: impact of tri-dimensional structure and stromal cells on sensitivity of human tumors to drug treatment.
Abstract (Englisch)	Screening of anticancer drugs is currently performed on established human tumor cell lines cultured in monolayers. Predictive value is modest as shown by low success rate of compounds entering clinical studies possibly due to cell selection within permanent cell lines and to absence of tridimensional (3D) structure or tumor-stroma interaction. In this project advances in the 3D culture of primary cancer cells and mesenchymal stromal cells (MSC), and progress in cell imaging technology will be used to establish novel platforms for anticancer drug evaluation.

Kategorie

Text

Kurzbeschreibung
(Englisch)

Development and validation of highly predictive anticancer compound screening (HIPACS) systems: impact of tri-dimensional structure and stromal cells on sensitivity of human tumors to drug treatment.

Abstract
(Englisch)

Screening of anticancer drugs is currently performed on established human tumor cell lines cultured in monolayers. Predictive value is modest as shown by low success rate of compounds entering clinical studies possibly due to cell selection within permanent cell lines and to absence of tridimensional (3D) structure or tumor-stroma interaction. In this project advances in the 3D culture of primary cancer cells and mesenchymal stromal cells (MSC), and progress in cell imaging technology will be used to establish novel platforms for anticancer drug evaluation.